Benjamin A Howell1, Lisa Puglisi1, Katie Clark2, Carmen Albizu-Garcia3, Evan Ashkin4, Tyler Booth5, Lauren Brinkley-Rubinstein4, David A Fiellin6, Aaron D Fox7, Kathleen F Maurer8, Hsiu-Ju Lin9, Kathryn McCollister10, Sean Murphy11, Diane S Morse12, Shira Shavit13, Karen Wang14, Tyler Winkelman15, Emily A Wang16. 1. SEICHE Center for Health and Justice, Yale School of Medicine, New Haven, CT, United States of America; Yale Program in Addiction Medicine, Yale School of Medicine, New Haven, CT, United States of America; Section of General Internal Medicine, Yale School of Medicine, New Haven, CT, United States of America. 2. SEICHE Center for Health and Justice, Yale School of Medicine, New Haven, CT, United States of America. 3. University of Puerto Rico, San Juan, PR, United States of America. 4. University of North Carolina, Chapel Hill, NC, United States of America. 5. InterCommunity Health Care, East Hartford, CT, United States of America. 6. Yale Program in Addiction Medicine, Yale School of Medicine, New Haven, CT, United States of America; Section of General Internal Medicine, Yale School of Medicine, New Haven, CT, United States of America. 7. Division of General Internal Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, United States of America. 8. VitalCore Health Strategies, Topeka, KS, United States of America. 9. University of Connecticut, Storrs, CT, United States of America. 10. University of Miami, Miami, FL, United States of America. 11. Weill Cornell Medical College, New York, NY, United States of America. 12. University of Rochester, School of Medicine, Rochester, NY, United States of America. 13. University of California, San Francisco, CA. 14. Section of General Internal Medicine, Yale School of Medicine, New Haven, CT, United States of America. 15. Health, Homelessness, and Criminal Justice Lab, Hennepin Healthcare Research Institute, Minneapolis, MN, United States of America; Division of General Internal Medicine, Department of Medicine, Hennepin Healthcare, Minneapolis, MN, United States of America. 16. SEICHE Center for Health and Justice, Yale School of Medicine, New Haven, CT, United States of America; Yale Program in Addiction Medicine, Yale School of Medicine, New Haven, CT, United States of America; Section of General Internal Medicine, Yale School of Medicine, New Haven, CT, United States of America. Electronic address: emily.wang@yale.edu.
Abstract
BACKGROUND: In 2016, at least 20% of people with opioid use disorder (OUD) were involved in the criminal justice system, with the majority of individuals cycling through jails. Opioid overdose is the leading cause of death and a common cause of morbidity after release from incarceration. Medications for OUD (MOUD) are effective at reducing overdoses, but few interventions have successfully engaged and retained individuals after release from incarceration in treatment. OBJECTIVE: To assess whether follow-up care in the Transitions Clinic Network (TCN), which provides OUD treatment and enhanced primary care for people released from incarceration, improves key measures in the opioid treatment cascade after release from jail. In TCN programs, primary care teams include a community health worker with a history of incarceration, and they attend to social needs, such as housing, food insecurity, and criminal legal system contact, along with patients' medical needs. METHODS AND ANALYSIS: We will bring together six correctional systems and community health centers with TCN programs to conduct a hybrid type-1 effectiveness/implementation study among individuals who were released from jail on MOUD. We will randomize 800 individuals on MOUD released from seven local jails (Bridgeport, CT; Niantic, CT; Bronx, NY; Caguas, PR; Durham, NC; Minneapolis, MN; Ontario County, NY) to compare the effectiveness of a TCN intervention versus referral to standard primary care to improve measures within the opioid treatment cascade. We will also determine what social determinants of health are mediating any observed associations between assignment to the TCN program and opioid treatment cascade measures. Last, we will study the cost effectiveness of the approach, as well as individual, organizational, and policy-level barriers and facilitators to successfully transitioning individuals on MOUD from jail to the TCN. ETHICS AND DISSEMINATION: Investigation Review Board the University of North Carolina (IRB Study # 19-1713), the Office of Human Research Protections, and the NIDA JCOIN Data Safety Monitoring Board approved the study. We will disseminate study findings through peer-reviewed publications and academic and community presentations. We will disseminate study data through a web-based platform designed to share data with TCN PATHS participants and other TCN stakeholders. Clinical trials.gov registration: NCT04309565.
BACKGROUND: In 2016, at least 20% of people with opioid use disorder (OUD) were involved in the criminal justice system, with the majority of individuals cycling through jails. Opioid overdose is the leading cause of death and a common cause of morbidity after release from incarceration. Medications for OUD (MOUD) are effective at reducing overdoses, but few interventions have successfully engaged and retained individuals after release from incarceration in treatment. OBJECTIVE: To assess whether follow-up care in the Transitions Clinic Network (TCN), which provides OUD treatment and enhanced primary care for people released from incarceration, improves key measures in the opioid treatment cascade after release from jail. In TCN programs, primary care teams include a community health worker with a history of incarceration, and they attend to social needs, such as housing, food insecurity, and criminal legal system contact, along with patients' medical needs. METHODS AND ANALYSIS: We will bring together six correctional systems and community health centers with TCN programs to conduct a hybrid type-1 effectiveness/implementation study among individuals who were released from jail on MOUD. We will randomize 800 individuals on MOUD released from seven local jails (Bridgeport, CT; Niantic, CT; Bronx, NY; Caguas, PR; Durham, NC; Minneapolis, MN; Ontario County, NY) to compare the effectiveness of a TCN intervention versus referral to standard primary care to improve measures within the opioid treatment cascade. We will also determine what social determinants of health are mediating any observed associations between assignment to the TCN program and opioid treatment cascade measures. Last, we will study the cost effectiveness of the approach, as well as individual, organizational, and policy-level barriers and facilitators to successfully transitioning individuals on MOUD from jail to the TCN. ETHICS AND DISSEMINATION: Investigation Review Board the University of North Carolina (IRB Study # 19-1713), the Office of Human Research Protections, and the NIDA JCOIN Data Safety Monitoring Board approved the study. We will disseminate study findings through peer-reviewed publications and academic and community presentations. We will disseminate study data through a web-based platform designed to share data with TCN PATHS participants and other TCN stakeholders. Clinical trials.gov registration: NCT04309565.
Authors: David A Wohl; Anna Scheyett; Carol E Golin; Becky White; Jeanine Matuszewski; Michael Bowling; Paula Smith; Faye Duffin; David Rosen; Andrew Kaplan; JoAnne Earp Journal: AIDS Behav Date: 2011-02
Authors: Byron Alex; David B Weiss; Fatos Kaba; Zachary Rosner; David Lee; Sungwoo Lim; Homer Venters; Ross MacDonald Journal: J Correct Health Care Date: 2017-01-01
Authors: Christopher M Jones; Melinda Campopiano; Grant Baldwin; Elinore McCance-Katz Journal: Am J Public Health Date: 2015-06-11 Impact factor: 9.308
Authors: Gail D'Onofrio; Patrick G O'Connor; Michael V Pantalon; Marek C Chawarski; Susan H Busch; Patricia H Owens; Steven L Bernstein; David A Fiellin Journal: JAMA Date: 2015-04-28 Impact factor: 56.272
Authors: Sungwoo Lim; Amber Levanon Seligson; Farah M Parvez; Charles W Luther; Maushumi P Mavinkurve; Ingrid A Binswanger; Bonnie D Kerker Journal: Am J Epidemiol Date: 2012-02-13 Impact factor: 4.897
Authors: Sean M Murphy; Neda Laiteerapong; Mai T Pho; Danielle Ryan; Iván Montoya; Theresa I Shireman; Elbert Huang; Kathryn E McCollister Journal: J Subst Abuse Treat Date: 2021-01-06
Authors: Cayley Russell; Michelle Pang; Frishta Nafeh; Shanna Farrell Macdonald; Dena Derkzen; Jürgen Rehm; Benedikt Fischer Journal: Int J Qual Stud Health Well-being Date: 2022-12